Biopure gets Nasdaq extension

Biopure (Cambridge, Massachusetts) said it has received notice from the Nasdaq Stock Market stating that Nasdaq has again suspended enforcement of its minimum bid price and market value requirements for continued listing, thereby extending the company's time in which to gain compliance. Enforcement of these rules is scheduled to resume on April 20.

Biopure makes pharmaceuticals called oxygen therapeutics that are intravenously administered to deliver oxygen to the body's tissues.

Johns Hopkins brain sciences center to open

The Forest City-New East Baltimore Partnership (FCNEBP; Baltimore) said that the Brain Sciences Institute of the Johns Hopkins University School of Medicine (BSI; also Baltimore) will locate at 855 North Wolfe Street, in the John G. Rangos Sr., Building, within the Science + Technology Park at Johns Hopkins.

BSI will occupy 25,000 square feet of laboratory space on the second floor, co-located with new laboratory space used by the Johns Hopkins Neurology Department.

BSI was established to help stimulate advances in fundamental neuroscience and to translate new discoveries into novel treatments for major neurological diseases. Brain Sciences Institute draws from a wide spectrum of Johns Hopkins University faculty scientists and clinicians. The new location in the Rangos Building will be the center of the institute's operations.

The Science + Technology Park at Johns Hopkins, which is being developed by The Forest City-New East Baltimore Partnership, is part of a mixed-use development program in an area of East Baltimore immediately north of the Johns Hopkins Medical Institutions. The first phase of the development includes the 1.1-million-square-foot Science + Technology Park, over 850 housing units for mixed-income buyers and renters, and a variety of retail services.